Ruxolitinib: FDA adverse event reports
80,746 FDA FAERS reports mention Ruxolitinib. 43,948 reports have a serious outcome flag.
Reported reactions
- Off Label Use: 14,680 reports
- Death: 7,585 reports
- Fatigue: 6,471 reports
- Anaemia: 4,138 reports
- Haemoglobin Decreased: 3,730 reports
- Platelet Count Decreased: 3,509 reports
- Diarrhoea: 3,016 reports
- Asthenia: 2,872 reports
- Pneumonia: 2,744 reports
- Dizziness: 2,733 reports
- Product Dose Omission Issue: 2,680 reports
- Headache: 2,664 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.